FIELD: medicine, phthisiology.
SUBSTANCE: additionally to chemotherapy including combination of antituberculous preparations based upon isoniazide or isoniazide and rifampicin one should prescribe zinc sulfate at daily dosage being 2.30-35 mg/kg due to twice or thrice oral intake during 21-28 d. The present innovation enables to shorten period of chemotherapy due to taking antilogarithms for the action of chemopreparations with zinc sulfate.
EFFECT: higher efficiency of therapy.
6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| METHOD FOR CHOOSING THERAPEUTIC APPROACH FOR PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS | 2015 |
|
RU2602683C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2019 |
|
RU2710266C1 |
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
| METHOD FOR TREATMENT OF PULMONARY ORGANS TUBERCULOSIS | 2005 |
|
RU2299068C2 |
| METHOD FOR PREDICTING THE SURVIVAL PERIOD OF PATIENTS WITH THE CLINICAL COURSE OF HIV AND TUBERCULOSIS COINFECTION, ACCOMPANIED BY MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2021 |
|
RU2764830C1 |
